Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat [Yahoo! Finance]
Precigen, Inc. (PGEN)
Last precigen, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
papillomatosis (RRP), has entered commercial launch with dosing since November and reports over 300 patients in its manufacturer hub plus broad payer coverage (~215 million commercial and ~300 million including Medicare/Medicaid). Built on a proprietary gorilla adenovirus platform that enables higher payloads and repeat dosing while favoring CD8 T-cell responses, Papzimeos showed a 51% complete response rate in the pivotal trial, an 86% overall reduction in surgeries, and durable responses in some patients beyond three years. A permanent J-code is expected to streamline institutional reimbursement, Precigen plans pediatric Papzimeos trials by end-2026 and redosing data in 2028, and the company is advancing PRGN-2009 (HPV16/18) into phase II with early combo data showing a 30% objective response rate and initial head-and-neck data due by end-2026. Interested in Precigen, Inc.? Here are five stocks we like better. Precigen (NASDAQ:PGEN) executives used a fireside chat hosted by
Show less
Read more
Impact Snapshot
Event Time:
PGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGEN alerts
High impacting Precigen, Inc. news events
Weekly update
A roundup of the hottest topics
PGEN
News
- Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? [Yahoo! Finance]Yahoo! Finance
- Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects [Yahoo! Finance]Yahoo! Finance
- Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point [Seeking Alpha]Seeking Alpha
- Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript [Seeking Alpha]Seeking Alpha
- Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31PR Newswire
PGEN
Earnings
- 3/25/26 - Miss
PGEN
Sec Filings
- 3/31/26 - Form 4
- 3/31/26 - Form SCHEDULE
- 3/30/26 - Form 144
- PGEN's page on the SEC website